Tag

Prostate cancer
24
Jun

Robust PSA Drops With Radionuclide Therapy in Castration-Resistant Prostate Cancer

An investigational radionuclide therapy targeting prostate-specific membrane antigen (PSMA) achieved biochemical responses in 70% of patients with castration-resistant prostate cancer (CRPC), and prostate-specific antigen (PSA) reductions in all but one patient, enrolled in a small preliminary clinical trial.

Read More

16
Feb

MRI-Guided RT Reduced Acute Toxic Effects in Men With Localised Prostate Cancer

Stereotactic body radiotherapy (SBRT) guided by MRI for localised prostate cancer resulted in fewer toxicities and an improvement in quality of life compared with CT guidance, according to the randomised phase III MIRAGE trial.

Read More

28
Jan

MRI-Targeted Biopsy for Prostate Cancer Reduces Risk of Overdiagnosis

Excluding systematic biopsy in favour of MRI-targeted biopsy in men with elevated prostate-specific antigen (PSA) levels reduced the probability of detecting clinically insignificant cancers, but at the risk of missing some clinically significant cancers and delaying their diagnosis.

Read More

10
Jan

Can Oncologists Reduce the Suicide Risk in Their Prostate Cancer Patients?

Whether it’s due to the side effects of local and systemic therapies, or the diagnosis itself, men with prostate cancer are at increased risk of mental distress and suicide. The mental health burden associated with a diagnosis and treatment is substantial, pointed out Zachary Klaassen, MD, of the Georgia Cancer Center at Augusta University.

Read More

15
Apr

Metastatic prostate cancer cases surge following USPSTF-recommended slowdown in screenings

Source: Metastatic prostate cancer cases surged following the issuance of U.S. Preventive Services Task Force recommendations against routine screening for the disease, according to research published Monday. It was back in 2008 that the influential panel of experts urged against regular prostate-specific antigen testing among men older than 75, which spread to all ages by...

Read More

04
Feb

AI Accurately Diagnoses Prostate Cancer

Source: Researchers at Karolinska Institutet in Sweden, together with international collaborators, have completed a comprehensive international validation of artificial intelligence (AI) for diagnosing and grading prostate cancer.

Read More

07
Apr

mpMRI reduces unnecessary prostate biopsies

Using multiparametric MRI (mpMRI) to image men suspected of having prostate cancer can reduce unnecessary biopsies by more than a third and increase the detection of clinically significant disease by more than 50%. By Kate Madden Yee, AuntMinnie.com staff writer

Read More

22
Jan

Prostate MRI scoring system can standardize reporting, improve decision-making

“Integration of a scoring system into structured prostate MRI reports could be of great value to clinical research as well as routine clinical care..." Matt O'Connor | Imaging Informatics | Health Imaging

Read More

09
Jan

More men with low-risk prostate cancer are choosing active surveillance

Traditionally, men with low-risk prostate cancer had undergone radical prostatectomy or radiation, but many are now opting for a more conservative active surveillance approach. Matt O'Connor | Oncology Imaging | Health Imaging

Read More

03
Mar

Combined MRI, US-guided biopsy detects more prostate cancers

Biopsy guided by ultrasound (US) is the traditional method to determine if men have prostate cancer. But a new study found adding MRI-guided biopsy can increase the rate of prostate cancer detection. Matt O'Connor | Oncology Imaging | Health Imaging

Read More

1 2

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. Gloreen G at GCG has vast experience and understanding of the specialist medical and diagnostic imaging market. This gives GCG the ability to ensure that you receive the very best salary and incentives package, including leave entitlements, days off, paid conferences and radiology expenses.